Author： Beckett R.P. Whittaker M.
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.8, Iss.3, 1998-03, pp. : 259-282
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Matrix metalloproteinase inhibitors
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. :
Access to resources
Recommend
Matrix metalloproteinase inhibitors and cancer
By Lauer-Fields J.L. Fields G.B.
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. :
Ongoing trials with matrix metalloproteinase inhibitors
By Brown P.D.
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 9, 2000-09 ,pp. :
Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics
Current Cancer Drug Targets, Vol. 5, Iss. 4, 2005-06 ,pp. :
Progress in the Development of Matrix Metalloproteinase Inhibitors
Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. :